Insmed Inc. buy Barclays PLC
Start price
29.05.24
/
50%
€43.00
Target price
29.05.25
€58.07
Performance (%)
43.02%
End price
30.05.25
€61.50
Summary
This prediction ended on 30.05.25 with a price of €61.50. With a performance of 43.02% the BUY prediction by Barclays_PLC was a big success. Barclays_PLC has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -5.109% | -5.109% | 109.677% |
| iShares Core DAX® | 0,44 % | 3,03 % | 12,68 % |
| iShares Nasdaq 100 | 3,82 % | 4,07 % | 33,15 % |
| iShares Nikkei 225® | 1,15 % | 6,90 % | 45,49 % |
| iShares S&P 500 | 2,37 % | 2,68 % | 25,69 % |
Comments by Barclays_PLC for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Barclays PLC from $40.00 to $63.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten